Tango Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	53.15	66.39	59.97	142.75	28.38	22.89
Short-Term Investments	240.13	270.5	306.17	342.51	161.94	17.54
Cash & Short-Term Investments	293.28	336.89	366.13	485.26	190.32	40.43
Cash Growth	-18.51%	-7.99%	-24.55%	154.97%	370.80%	-
Receivables	-	-	2	2	2	-
Prepaid Expenses	7.54	8.8	6.57	4.52	1.31	1.23
Restricted Cash	-	0.86	0.57	0.57	-	-
Total Current Assets	300.82	346.54	375.27	492.34	193.63	41.66
Property, Plant & Equipment	49.02	53.42	57.77	6.09	11.3	11.83
Other Long-Term Assets	2.58	2.61	3.43	1.73	2.32	2.28
Total Assets	352.42	402.57	436.47	500.16	207.25	55.76
Accounts Payable	4.11	2.79	4.45	3.23	1.84	0.67
Accrued Expenses	12.26	14.11	16.23	9.22	5.35	4.59
Current Portion of Leases	2.86	2.08	1.77	1.5	0.96	0.66
Current Income Taxes Payable	-	-	0.04	0.05	-	-
Current Unearned Revenue	15.6	25.67	31.79	26.02	31.98	19.59
Other Current Liabilities	2.75	1.29	1.27	0.67	0.79	0.34
Total Current Liabilities	37.58	45.94	55.55	40.69	40.92	25.85
Long-Term Leases	34.76	36.84	39.36	-	6.93	7.88
Long-Term Unearned Revenue	50.9	66.68	92.09	114.72	120.81	14.11
Other Long-Term Liabilities	-	-	-	-	0.01	0.02
Total Liabilities	123.25	149.46	186.99	155.41	168.65	47.86
Common Stock	0.11	0.1	0.09	0.09	0.04	0.01
Additional Paid-In Capital	692.2	624.08	522.61	506.76	141.64	3.31
Retained Earnings	-463.89	-371.26	-269.51	-161.34	-103.1	-51.13
Comprehensive Income & Other	0.75	0.19	-3.71	-0.77	0.02	0.01
Total Common Equity	229.17	253.11	249.48	344.75	38.6	-47.8
Shareholders' Equity	229.17	253.11	249.48	344.75	38.6	7.91
Total Liabilities & Equity	352.42	402.57	436.47	500.16	207.25	55.76
Total Debt	37.63	38.92	41.13	1.5	7.88	8.54
Net Cash (Debt)	255.65	297.97	325	483.75	182.44	31.89
Net Cash Growth	-20.20%	-8.32%	-32.82%	165.16%	472.15%	-
Net Cash Per Share	2.37	3.15	3.70	7.79	5.71	3.55
Filing Date Shares Outstanding	107.42	106.72	88.2	87.71	14.2	8.99
Total Common Shares Outstanding	107.41	102.2	88.18	87.6	13.3	8.99
Working Capital	263.23	300.6	319.73	451.65	152.72	15.81
Book Value Per Share	2.13	2.48	2.83	3.94	2.90	-5.32
Tangible Book Value	229.17	253.11	249.48	344.75	38.6	-47.8
Tangible Book Value Per Share	2.13	2.48	2.83	3.94	2.90	-5.32
Machinery	13.19	12.88	11.65	6.25	5.14	4.24
Construction In Progress	0.17	0.04	0.01	0.74	-	-
Leasehold Improvements	2.86	2.86	2.78	0.25	0.25	0.23

Source: S&P Capital IQ. Standard template. Financial Sources.